Established in 1971, Streck’s founder, Dr. Wayne Ryan, developed the company’s core technology of cell stabilization at a time when blood cells were still being counted manually using microscopes.
Streck researchers were able to facilitate automatic counting, leading to the development of an accurate system for calibrating platelet-counting devices. It was a profound breakthrough for hematology laboratories around the world – one that fueled their pursuit of innovative solutions for the clinical laboratory.
Today, innovation continues to drive their science. Streck holds over 40 patents on more than 20 products and makes testing and reagent materials for some of the industry’s leading instrument manufacturers.
Streck’s body fluid control products include manual and automated body fluid controls, sperm count controls and patient-like urinalysis controls assayed for multiple platforms.
Based on Streck’s proprietary cell-stabilization technology, Streck offers a comprehensive line of positive procedural controls providing assay values for both normal and abnormal leukocyte populations and reference values for both intracellular and surface markers.
Streck’s HbA1c product line includes a control and linearity assessment with intact red blood cells to challenge the entire HbA1c procedure, including the lysing of the red blood cells.
Streck’s line of Hematology controls and calibrators are available for most brands of hematology analyzers and come in multiple levels to test accuracy and sensitivity.
Streck has a full line of sickle solubility qualitative test kits and quality control materials.
Accessories & Services
Streck’s portfolio of NIST-traceable thermometers and Streck’s STATS – interlaboratory quality assurance program.